• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坏死相关的 p53 聚集在 MCF-7 多细胞肿瘤球体对 5-FU 获得性凋亡抵抗中的意义。

Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids.

机构信息

Department of Molecular Biology, College of Natural Sciences, Pusan National University, Pusan 609-735, Korea.

出版信息

Oncol Rep. 2010 Jul;24(1):73-9.

PMID:20514446
Abstract

Three-dimensional (3D) multicellular tumour spheroids (MTS) have been used as an in vitro model of solid tumours for drug resistance studies because they mimic the growth characteristics of in vivo tumours more closely than in vitro two-dimensional (2D) culture of cancer cell lines. As observed in solid tumours, MTS exhibits a proliferation gradient with outer regions consisting of proliferating cells that surround inner quiescent cells. The innermost cells in core regions undergo cell death mostly by necrosis to form necrotic core due to insufficient supply of oxygen and nutrient such as glucose with increasing size of spheroids. Tumour necrosis is thought to indicate a poor prognosis and to contribute to acquisition of chemoresistance in solid tumours; however, the mechanism underlying necrosis-mediated chemoresistance remains unclear. In this study, we examined the chemoresistance to 5-Fluorouracil (5-FU) using MCF-7 breast cancer MTS. 5-FU (400 microM) induced apoptosis in MCF-7 cell monolayer as determined by HO/PI staining, PARP cleavage, p53 induction, Bax induction, and Bcl-2 down-regulation. When MCF-7 breast tumour spheroids were cultured on agarose for 8 days, they reached approximately 700 microm in diameter, with a necrotic core. We found that 5-FU-induced apoptosis is markedly reduced in spheroids that were cultured for 9 days and had necrotic core, compared with MCF-7 monolayer cells and spheroids that were cultured for 6 days and had no necrotic core, indicating that the formation of necrotic core may be linked to acquisition of chemoresistance to 5-FU. We also found that a specific set of cellular proteins including p53 was aggregated into a RIPA-insoluble form during MTS culture. Furthermore, most of p53 induced by 5-FU was aggregated in MTS with necrotic core. Our results suggest that necrosis-linked p53 aggregation may contribute to acquired apoptotic resistance to 5-FU in MTS model system.

摘要

三维(3D)多细胞肿瘤球体(MTS)已被用作药物耐药性研究的体外模型,因为它们比体外二维(2D)培养的癌细胞系更能模拟体内肿瘤的生长特征。与实体瘤一样,MTS 表现出增殖梯度,外区由增殖细胞组成,内区由静止细胞组成。随着球体的增大,核心区域的最内层细胞由于氧气和葡萄糖等营养物质供应不足而主要通过坏死发生细胞死亡,形成坏死核心。肿瘤坏死被认为预示着预后不良,并有助于实体瘤获得化疗耐药性;然而,坏死介导的化疗耐药性的机制尚不清楚。在这项研究中,我们使用 MCF-7 乳腺癌 MTS 研究了对 5-氟尿嘧啶(5-FU)的化疗耐药性。HO/PI 染色、PARP 切割、p53 诱导、Bax 诱导和 Bcl-2 下调表明,5-FU(400 μM)诱导 MCF-7 细胞单层中的细胞凋亡。当 MCF-7 乳腺癌球体在琼脂糖上培养 8 天时,它们的直径约为 700 μm,形成坏死核心。我们发现,与 MCF-7 单层细胞和培养 6 天且无坏死核心的球体相比,培养 9 天且有坏死核心的球体中 5-FU 诱导的细胞凋亡明显减少,这表明坏死核心的形成可能与对 5-FU 的化疗耐药性有关。我们还发现,一组特定的细胞蛋白,包括 p53,在 MTS 培养过程中聚集形成 RIPA 不溶性形式。此外,5-FU 诱导的 p53 大部分在有坏死核心的 MTS 中聚集。我们的结果表明,与坏死相关的 p53 聚集可能有助于在 MTS 模型系统中获得对 5-FU 的凋亡抵抗。

相似文献

1
Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids.坏死相关的 p53 聚集在 MCF-7 多细胞肿瘤球体对 5-FU 获得性凋亡抵抗中的意义。
Oncol Rep. 2010 Jul;24(1):73-9.
2
Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.Bcl-2/Bax蛋白比率可独立于p53状态预测5-氟尿嘧啶敏感性。
Br J Cancer. 2000 Nov;83(10):1380-6. doi: 10.1054/bjoc.2000.1455.
3
Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.在用蛋白酶体抑制剂PS - 341治疗的人类卵巢癌和前列腺癌中未观察到多细胞耐药性。
Clin Cancer Res. 2000 Sep;6(9):3719-28.
4
Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing.利用微囊化技术构建体外多细胞肿瘤球体模型及其在抗癌药物筛选与测试中的应用
Biotechnol Prog. 2005 Jul-Aug;21(4):1289-96. doi: 10.1021/bp050003l.
5
Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.评估热休克蛋白90(Hsp90)抑制剂NVP - AUY922在多细胞肿瘤球体中对生长和PET示踪剂摄取的影响。
Nucl Med Biol. 2009 Apr;36(3):335-42. doi: 10.1016/j.nucmedbio.2008.12.009.
6
Modelling the formation of necrotic regions in avascular tumours.模拟无血管肿瘤中坏死区域的形成。
Math Biosci. 2008 Jan;211(1):34-55. doi: 10.1016/j.mbs.2007.09.002. Epub 2007 Oct 5.
7
The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.从诱导凋亡方面评估胃癌对5-氟尿嘧啶/顺铂的敏感性:抗癌药物的时间和p53表达依赖性
Oncol Rep. 2005 Sep;14(3):609-15.
8
The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.胸苷酸合成酶诱导在调节p53调控的基因表达以响应5-氟尿嘧啶和抗叶酸药物中的作用。
Cancer Res. 2002 May 1;62(9):2644-9.
9
Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells.细胞外信号调节激酶(ERK)1/2 在 MCF-7 细胞多细胞对多西紫杉醇耐药中的作用。
Int J Oncol. 2010 Sep;37(3):655-61. doi: 10.3892/ijo_00000714.
10
Induction of cell death by Doxorubicin in multicellular spheroids as studied by confocal laser scanning microscopy.通过共聚焦激光扫描显微镜研究阿霉素对多细胞球体中细胞死亡的诱导作用。
Anticancer Res. 1996 Mar-Apr;16(2):573-9.

引用本文的文献

1
Understanding the prion-like behavior of mutant p53 proteins in triple-negative breast cancer pathogenesis: The current therapeutic strategies and future directions.了解三阴性乳腺癌发病机制中突变型p53蛋白的朊病毒样行为:当前的治疗策略和未来方向。
Heliyon. 2024 Feb 10;10(4):e26260. doi: 10.1016/j.heliyon.2024.e26260. eCollection 2024 Feb 29.
2
Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches.解析乳腺癌和卵巢癌干细胞的共同特征及可能的治疗方法。
Int J Mol Sci. 2023 Jun 26;24(13):10683. doi: 10.3390/ijms241310683.
3
Anticancer Therapeutic Strategies Targeting p53 Aggregation.
靶向 p53 聚集的抗癌治疗策略。
Int J Mol Sci. 2022 Sep 20;23(19):11023. doi: 10.3390/ijms231911023.
4
Caffeic Acid, Quercetin and 5-Fluorocytidine-Functionalized Au-FeO Nanoheterodimers for X-ray-Triggered Drug Delivery in Breast Tumor Spheroids.用于X射线触发的乳腺癌球状体药物递送的咖啡酸、槲皮素和5-氟胞苷功能化金-氧化铁纳米异质二聚体
Nanomaterials (Basel). 2021 Apr 29;11(5):1167. doi: 10.3390/nano11051167.
5
The Role of Biomimetic Hypoxia on Cancer Cell Behaviour in 3D Models: A Systematic Review.仿生缺氧在三维模型中对癌细胞行为的作用:一项系统综述。
Cancers (Basel). 2021 Mar 16;13(6):1334. doi: 10.3390/cancers13061334.
6
Regulation of Tumor Progression by Programmed Necrosis.程序性细胞坏死对肿瘤进展的调控。
Oxid Med Cell Longev. 2018 Jan 31;2018:3537471. doi: 10.1155/2018/3537471. eCollection 2018.
7
Improvement of the BALB/c-3T3 cell transformation assay: a tool for investigating cancer mechanisms and therapies.改良 BALB/c-3T3 细胞转化试验:一种用于研究癌症机制和疗法的工具。
Sci Rep. 2016 Sep 9;6:32966. doi: 10.1038/srep32966.
8
Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation.BAP1催化结构域中与癌症相关的错义突变诱导淀粉样蛋白聚集:酶失活的新见解。
Sci Rep. 2015 Dec 18;5:18462. doi: 10.1038/srep18462.
9
The multiple facets of drug resistance: one history, different approaches.耐药性的多方面:一段历史,不同方法。
J Exp Clin Cancer Res. 2014 Apr 28;33(1):37. doi: 10.1186/1756-9966-33-37.
10
The aggregation of mutant p53 produces prion-like properties in cancer.突变型p53的聚集在癌症中产生类朊病毒特性。
Prion. 2014 Jan-Feb;8(1):75-84. doi: 10.4161/pri.27776.